These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Braun J; Brandt J; Listing J; Zink A; Alten R; Burmester G; Golder W; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Reddig J; Sieper J Arthritis Rheum; 2003 Aug; 48(8):2224-33. PubMed ID: 12905476 [TBL] [Abstract][Full Text] [Related]
10. Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice. Haibel H; Song IH; Rudwaleit M; Listing J; Hildemann S; Sieper J Clin Exp Rheumatol; 2008; 26(2):247-52. PubMed ID: 18565245 [TBL] [Abstract][Full Text] [Related]
11. Maintained clinical response of infliximab treatment in ankylosing spondylitis: a 6-year long-term study. Saougou I; Markatseli TE; Voulgari PV; Drosos AA Joint Bone Spine; 2010 Jul; 77(4):325-9. PubMed ID: 20452801 [TBL] [Abstract][Full Text] [Related]
12. Quality of Life and Clinical Response to On-Demand Maintenance Doses of Infliximab in Patients With Ankylosing Spondylitis. Sengupta S; Ray J; Ghosh B J Clin Rheumatol; 2015 Oct; 21(7):355-8. PubMed ID: 26398462 [TBL] [Abstract][Full Text] [Related]
13. Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study. Mulleman D; Lauféron F; Wendling D; Ternant D; Ducourau E; Paintaud G; Goupille P Arthritis Res Ther; 2011 Jun; 13(3):R82. PubMed ID: 21639907 [TBL] [Abstract][Full Text] [Related]
14. Low-dose infliximab treatment for ankylosing spondylitis--clinically- and cost-effective. Jois RN; Leeder J; Gibb A; Gaffney K; Macgregor A; Somerville M; Scott DG Rheumatology (Oxford); 2006 Dec; 45(12):1566-9. PubMed ID: 16705043 [TBL] [Abstract][Full Text] [Related]
15. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis. Cui Y; Xiao Z; Shuxia W; Zhenjun Z; Hengguo Z; Liangyi F; Weicheng G; Li L; Guangfeng Z; Yunzhen S; Guangfu D Scand J Rheumatol; 2010 May; 39(3):229-32. PubMed ID: 20109079 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement. Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681 [TBL] [Abstract][Full Text] [Related]
17. A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis. Kobayashi S; Yoshinari T Mod Rheumatol; 2017 Jan; 27(1):142-149. PubMed ID: 27299733 [TBL] [Abstract][Full Text] [Related]
18. Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Ertenli I; Ozer S; Kiraz S; Apras SB; Akdogan A; Karadag O; Calguneri M; Kalyoncu U Rheumatol Int; 2012 Feb; 32(2):323-30. PubMed ID: 21079965 [TBL] [Abstract][Full Text] [Related]
19. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Marzo-Ortega H; McGonagle D; Jarrett S; Haugeberg G; Hensor E; O'connor P; Tan AL; Conaghan PG; Greenstein A; Emery P Ann Rheum Dis; 2005 Nov; 64(11):1568-75. PubMed ID: 15829577 [TBL] [Abstract][Full Text] [Related]
20. TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis. Nair AM; Sandhya P; Yadav B; Danda D Clin Rheumatol; 2017 Oct; 36(10):2243-2251. PubMed ID: 28646368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]